Subhash Saxena

Dr. Subhash Saxena holds a Ph.D. degree in Pharmaceutical Sciences and has over 37 years of industrial experience in the management of all aspects of product development, from concept through regulatory approval. He has a proven track record with several approved NDAs and ANDAs and IND, 510K and DMF filings for a number of therapeutic areas. Besides being responsible for the development of prescription products such as Retin-A™ Micro™ and Carac™, he has developed numerous skin care products marketed by SkinMedica, Intendis, Valeant, and Avon among others. Dr. Saxena was involved in the development of many new products including Microsponge™ drug delivery technology, holds multiple patents and is the author of numerous scientific publications. Since August 2009 he has been serving as the Vice President of R&D/Quality/ Regulatory at Jan Marini Skin Research in San Jose, CA.